Al­liance Pharma eyes bolt-on buys as sales lift

The Daily Telegraph - Business - - Business -

Spe­cial­ity phar­ma­ceu­ti­cal com­pany Al­liance Pharma said its sales were bol­stered by scar-di­min­ish­ing prod­ucts and treat­ments for age-re­lated vi­sion loss in the first half of 2017. Rev­enue rose 8.4pc year on year, to £50.3m, and un­der­ly­ing pre-tax profit was up 1.7pc. Al­liance said it was now be­gin­ning to look for bolt-on acquisitions.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.